UroAlert - GU Oncology Daily

November 14, 2024

Videos

Peer-to-Peer Clinical Conversations

The Future of Prostate Cancer Risk Stratification and Treatment Planning - Eric Kim

Preston Sprenkle and Eric Kim discuss the future of prostate cancer diagnostics, emphasizing the role of genomic classifiers like PAM50 and MRI in refining patient treatment plans.

BOND-003 Trial: Cretostimogene Grenadenorepvec Shows Promise in BCG-Unresponsive NMIBC - Mark Tyson

Mark Tyson

Sam Chang speaks with Mark Tyson about the BOND-003 trial's findings on cretostimogene grenadenorepvec for treating BCG unresponsive carcinoma in situ of the bladder.

Beyond the Abstracts

Exposures and Bladder Cancer Risk Among Military Veterans: A Systematic Review and Meta-analysis - Beyond the Abstract

Local Salvage Therapies in Patients with Radio-Recurrent Prostate Cancer Following External Beam Radiotherapy: A Systematic Review and Meta-Analysis - Beyond the Abstract

Conference Coverage

SCS AUA 2024: Multiparametric MRI in the Evaluation of Small Renal Masses

SCS AUA 2024: Can the PSMA PET SUVmax Predict High Risk Pathology and High Risk Disease? A Single Center Prospective Disease

SCS AUA 2024: Case Discussion: Management of Localized Renal Masses in Younger Patients and Patients with Heritable Kidney Cancer Syndromes

SCS AUA 2024: Indications and Outcomes for Radiation Therapy in Renal Masses

SCS AUA 2024: BCG Will Always Be the First Line: Yes

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Diagnostic significance of peritumoral enhancement in distinguishing between muscle-invasive and non-muscle-invasive bladder cancer.

An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial.

Induction Avelumab Followed by Chemoimmunotherapy and Maintenance Versus Chemotherapy Alone as First-Line Therapy in Cis-Ineligible Metastatic Urothelial Carcinoma (INDUCOMAIN): A Randomized Phase II Study

Renal Cancer

Urine leak and vascular complications following robotic partial nephrectomy: a contemporary single-center experience.

Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma.

Prostate Cancer

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

An Autophagy-Targeting Chimera Induces Degradation of Androgen Receptor Mutants and AR-v7 in Castration-Resistant Prostate Cancer.

Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL.

Imaging in Diagnosis and Active Surveillance for Prostate Cancer: A Review.

A pilot randomized clinical trial of a smartphone-based application to support at-home PSA screening and culturally tailored prostate cancer education for African American men: A study protocol.

PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2024 Digital Science Press, LLC